Astroglial reactivity is a key modulator of Alzheimer’s disease pathological progression

IF 10.6 1区医学 Q1 CLINICAL NEUROLOGY

Brain Pub Date : 2024-11-08 DOI:10.1093/brain/awae354

Wiesje Pelkmans, Juan Domingo Gispert

引用次数: 0

Abstract

This scientific commentary refers to ‘Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline’ by Peretti et al. (https://doi.org/10.1093/brain/awae211).

查看原文本刊更多论文

星形胶质细胞反应性是阿尔茨海默病病理进展的关键调节因子

本科学评论引用了 Peretti 等人撰写的 "神经胶质纤维酸蛋白、阿尔茨海默病病理和认知能力下降的关联 "一文 (https://doi.org/10.1093/brain/awae211)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Brain 医学-临床神经学

CiteScore

20.30

自引率

4.10%

发文量

458

审稿时长

3-6 weeks

期刊介绍： Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.